Specifically, tumor necrosis factor-alpha (TNF-α) drives bladder cancer metastasis via METTL3-mediated m6A modification of cytoplasmic Linker associated protein 2 (CLASP2). The gene discussed is TNF; the disease is urinary bladder cancer.